Description     Claims     Drawing  

WO2014089486A   [0003] 
WO2010053572A   [0090]  [0104] 
WO2012170930A   [0090] 
US61617468   [0090]  [0104] 
WO2013063468A   [0091] 
US4897355A   [0102] 
US5171678A   [0102] 
US5334761A   [0102] 
WO2010042877A   [0103] 
WO2005121348A1PCT   [0103] 
WO2012170889A   [0104] 
WO2011068810A   [0104] 
US61617468B   [0104] 
US5744335A   [0108] 
US5885613A   [0109] 
US4373071A   [0119] 
US4401796A   [0119] 
US4415732A   [0119] 
US4458066A   [0119] 
US4500707A   [0119] 
US4668777A   [0119] 
US4973679A   [0119] 
US5047524A   [0119] 
US5132418A   [0119] 
US5153319A   [0119] 
US5262530A   [0119] 
US5700642A   [0119] 
US8093367B   [0135] 
US8304529B   [0135] 
US4737323A   [0150] 
US61494882B   [0161] 
WO61135338A   [0210] 

J. Pharmaceutical Sciences   [0070] 
Trends Biotechnol.   [0089] 
Proc. Nat'l Acad. Sci.   [0102] 
Proc. Nat.'l Acad. Sci.   [0102] 
Nature Biotech.   [0103] 
J Controlled Release   [0103] 
Nat. Biotechnol.   [0103] 
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids   [0104]  [0183] 
Rational Design of Cationic Lipids for siRNA Delivery   [0104]  [0183] 
Lipid-like materials for low-dose in vivo gene silencing   [0104]  [0183] 
Biochem. Biophys. Res. Comm.   [0108] 
BioTechniques   [0108] 
FEBS Letters   [0109] 
Novel 'anti-reverse' cap analogs with superior translational properties   [0132] 
RNA   [0135] 
RNA   [0135] 
RNA   [0135] 
Nature Biotechnology   [0136] 
Molecular Cloning A Laboratory Manual   [0136] 
FEBS Lett.   [0145] 
Ann. Rev. Biophys. Bioeng.   [0150] 
Remington's Pharmaceutical Sciences   [0151] 
Recognition of mRNA cap structures by viral and cellular proteins   [0184]